Pfizer (PFE) EBIT (2009 - 2026)
Pfizer's EBIT was $5.47 billion in Q3 2026, down 15.4% from $6.46 billion a year earlier but up 28.2% from the prior quarter.
Powered by 
Analysis
Pfizer (PFE) EBIT (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Pfizer's EBIT was $19.4 billion through Sep 27, 2026, down 4.3% year-over-year; for FY2025, it came in at $20.73 billion, up 16.4% from FY2024.
- EBIT shows a five-year compound annual growth rate of 11.0% (FY2020 to FY2025).
- In earlier years, EBIT was $17.81 billion in FY2024 (+186.9%), $6.21 billion in FY2023 (-84.6%), $40.35 billion in FY2022 (+51.7%) and $26.6 billion in FY2021 (+116.6%).
- Quarterly EBIT has moved between -$2.95 billion (Q4 2023) and $13.04 billion (Q2 2022) over five years.
- Compared with a year earlier, EBIT was higher in four of the last seven quarters, with growth averaging 14.7%.
- The best year-over-year quarter for EBIT over five years was Q4 2021 (growth of 197.6%); the worst was Q2 2023 (a decline of 73.8%).
- Per Business Quant data, PFE's EBIT in the three quarters before Q3 2026 was $4.27 billion (Q2 2026), $5.35 billion (Q1 2026) and $4.31 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 8.41 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 5.56 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | 712.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2026 | 5.47 Bn |
| Jun 28, 2026 | 4.27 Bn |
| Mar 29, 2026 | 5.35 Bn |
| Dec 31, 2025 | 4.31 Bn |
| Sep 28, 2025 | 6.46 Bn |
| Jun 29, 2025 | 5.05 Bn |
| Mar 30, 2025 | 4.96 Bn |
| Dec 31, 2024 | 3.80 Bn |
| Sep 29, 2024 | 6.28 Bn |
| Jun 30, 2024 | 2.32 Bn |
| Mar 31, 2024 | 5.41 Bn |
| Dec 31, 2023 | -2.95 Bn |
| Oct 1, 2023 | -1.93 Bn |
| Jul 2, 2023 | 3.41 Bn |
| Apr 2, 2023 | 7.72 Bn |
| Dec 31, 2022 | 6.43 Bn |
| Oct 2, 2022 | 10.29 Bn |
| Jul 3, 2022 | 13.04 Bn |
| Apr 3, 2022 | 10.59 Bn |
| Dec 31, 2021 | 3.83 Bn |
API Access
Pfizer EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();